{"id":"https://openalex.org/W7221574479","doi":"https://doi.org/10.3389/fimmu.2026.1843935","title":"SCD1 inhibition promotes lipid peroxidation and enhances anti-PD-1 response in triple-negative breast cancer","display_name":"SCD1 inhibition promotes lipid peroxidation and enhances anti-PD-1 response in triple-negative breast cancer","publication_year":2026,"publication_date":"2026-10-12","ids":{"openalex":"https://openalex.org/W7221574479","doi":"https://doi.org/10.3389/fimmu.2026.1843935","pmid":"https://pubmed.ncbi.nlm.nih.gov/42936050","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13696522"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2026.1843935","doi":"https://doi.org/10.3389/fimmu.2026.1843935","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1843935","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1843935/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1843935/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5134153420","display_name":"Quentin Herrera Garfia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Quentin Herrera Garfia","raw_affiliation_strings":["Cancer Metabolism and Tumor Microenvironment Laboratory, Interdisciplinary Group for Applied Genoproteomics, University of Li\u00e8ge"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Metabolism and Tumor Microenvironment Laboratory, Interdisciplinary Group for Applied Genoproteomics, University of Li\u00e8ge","institution_ids":["https://openalex.org/I157674565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071096014","display_name":"Aur\u00e9lien Azam","orcid":"https://orcid.org/0000-0001-7680-4679","observed_orcids":["https://orcid.org/0000-0001-7680-4679"]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Aur\u00e9lien Azam","raw_affiliation_strings":["Cancer Metabolism and Tumor Microenvironment Laboratory, Interdisciplinary Group for Applied Genoproteomics, University of Li\u00e8ge"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Metabolism and Tumor Microenvironment Laboratory, Interdisciplinary Group for Applied Genoproteomics, University of Li\u00e8ge","institution_ids":["https://openalex.org/I157674565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058795992","display_name":"\u00c9ric Bonneil","orcid":"https://orcid.org/0000-0002-4039-3131","observed_orcids":["https://orcid.org/0000-0002-4039-3131"]},"institutions":[{"id":"https://openalex.org/I4210096154","display_name":"Institute for Research in Immunology and Cancer","ror":"https://ror.org/00wj6x496","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4210096154"]},{"id":"https://openalex.org/I70931966","display_name":"Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0161xgx34","country_code":"CA","type":"education","lineage":["https://openalex.org/I70931966"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Eric Bonneil","raw_affiliation_strings":["Institute for Research in Immunology and Cancer (IRIC), University of Montr\u00e9al"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Research in Immunology and Cancer (IRIC), University of Montr\u00e9al","institution_ids":["https://openalex.org/I4210096154","https://openalex.org/I70931966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088643291","display_name":"Laetitia Montero\u2010Ruiz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Laetitia Montero-Ruiz","raw_affiliation_strings":["Cancer Metabolism and Tumor Microenvironment Laboratory, Interdisciplinary Group for Applied Genoproteomics, University of Li\u00e8ge","Laboratory of Tumor and Development Biology Laboratory, Interdisciplinary Group for Applied Genoproteomics, University of Li\u00e8ge"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Metabolism and Tumor Microenvironment Laboratory, Interdisciplinary Group for Applied Genoproteomics, University of Li\u00e8ge","institution_ids":["https://openalex.org/I157674565"]},{"raw_affiliation_string":"Laboratory of Tumor and Development Biology Laboratory, Interdisciplinary Group for Applied Genoproteomics, University of Li\u00e8ge","institution_ids":["https://openalex.org/I157674565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5158468693","display_name":"Mohsen Momeni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Mohsen Momeni","raw_affiliation_strings":["Cancer Metabolism and Tumor Microenvironment Laboratory, Interdisciplinary Group for Applied Genoproteomics, University of Li\u00e8ge"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Metabolism and Tumor Microenvironment Laboratory, Interdisciplinary Group for Applied Genoproteomics, University of Li\u00e8ge","institution_ids":["https://openalex.org/I157674565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5138501218","display_name":"Mohammad Farran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Mohammad Farran","raw_affiliation_strings":["Cancer Metabolism and Tumor Microenvironment Laboratory, Interdisciplinary Group for Applied Genoproteomics, University of Li\u00e8ge"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Metabolism and Tumor Microenvironment Laboratory, Interdisciplinary Group for Applied Genoproteomics, University of Li\u00e8ge","institution_ids":["https://openalex.org/I157674565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115867123","display_name":"Robin Jehay","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Robin Jehay","raw_affiliation_strings":["Cancer Metabolism and Tumor Microenvironment Laboratory, Interdisciplinary Group for Applied Genoproteomics, University of Li\u00e8ge"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Metabolism and Tumor Microenvironment Laboratory, Interdisciplinary Group for Applied Genoproteomics, University of Li\u00e8ge","institution_ids":["https://openalex.org/I157674565"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045091637","display_name":"Nor Eddine Sounni","orcid":"https://orcid.org/0000-0001-9962-9236","observed_orcids":["https://orcid.org/0000-0001-9962-9236"]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"Nor Eddine Sounni","raw_affiliation_strings":["Cancer Metabolism and Tumor Microenvironment Laboratory, Interdisciplinary Group for Applied Genoproteomics, University of Li\u00e8ge"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Metabolism and Tumor Microenvironment Laboratory, Interdisciplinary Group for Applied Genoproteomics, University of Li\u00e8ge","institution_ids":["https://openalex.org/I157674565"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5045091637"],"corresponding_institution_ids":["https://openalex.org/I157674565"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.75223616,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1843935","last_page":"1843935"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9063000082969666,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9063000082969666,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11297","display_name":"Ferroptosis and cancer prognosis","score":0.08410000056028366,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.006399999838322401,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9490000009536743},{"id":"https://openalex.org/keywords/scd1-inhibition","display_name":"SCD1 inhibition","score":0.9610000252723694},{"id":"https://openalex.org/keywords/lipid-peroxidation","display_name":"lipid peroxidation","score":0.8500000238418579},{"id":"https://openalex.org/keywords/ferroptosis","display_name":"ferroptosis","score":0.9929999709129333},{"id":"https://openalex.org/keywords/rsl3","display_name":"RSL3","score":0.9350000023841858},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.8970000147819519},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.9010000228881836},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.9240000247955322},{"id":"https://openalex.org/keywords/interleukin-8","display_name":"interleukin-8","score":0.9150000214576721},{"id":"https://openalex.org/keywords/macrophage-migration-inhibitory-factor","display_name":"macrophage migration inhibitory factor","score":0.8999999761581421},{"id":"https://openalex.org/keywords/cd8-t-cell-infiltration","display_name":"CD8+ T cell infiltration","score":0.7749999761581421},{"id":"https://openalex.org/keywords/lag-3","display_name":"LAG-3","score":0.9459999799728394},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.5709999799728394},{"id":"https://openalex.org/keywords/lipid-metabolism","display_name":"lipid metabolism","score":0.4699999988079071}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7146999835968018},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6669999957084656},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.5734999775886536},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.5514000058174133},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5163000226020813},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.45820000767707825},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4417000114917755},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.44040000438690186},{"id":"https://openalex.org/C2780829032","wikidata":"https://www.wikidata.org/wiki/Q898539","display_name":"Lipid peroxidation","level":3,"score":0.37529999017715454},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.37310001254081726},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.37209999561309814},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.36489999294281006},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.3490999937057495},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.3472999930381775},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.3458000123500824},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.3325999975204468},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3181999921798706},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.31299999356269836},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.30469998717308044},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.30390000343322754},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2921000123023987},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.2921000123023987},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.2849000096321106},{"id":"https://openalex.org/C49039625","wikidata":"https://www.wikidata.org/wiki/Q84230","display_name":"Secretion","level":2,"score":0.2777999937534332},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2709999978542328},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.26109999418258667},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2574999928474426},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.2540999948978424},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.25200000405311584},{"id":"https://openalex.org/C4733338","wikidata":"https://www.wikidata.org/wiki/Q2792936","display_name":"Lipid metabolism","level":2,"score":0.2515000104904175},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.2506999969482422}],"mesh":[{"descriptor_ui":"D000079403","descriptor_name":"Ferroptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000092302","descriptor_name":"MDA-MB-231 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015227","descriptor_name":"Lipid Peroxidation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.3389/fimmu.2026.1843935","doi":"https://doi.org/10.3389/fimmu.2026.1843935","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1843935","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1843935/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13696522","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13696522/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13696522/pdf/fimmu-17-1843935.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:42936050","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42936050","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:3dd4943cfcc948ce912e5116d43a4aeb","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/3dd4943cfcc948ce912e5116d43a4aeb","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2026.1843935","doi":"https://doi.org/10.3389/fimmu.2026.1843935","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1843935","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1843935/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320321390","display_name":"Fonds De La Recherche Scientifique - FNRS","ror":"https://ror.org/03q83t159"},{"id":"https://openalex.org/F4320323329","display_name":"Universit\u00e9 de Li\u00e8ge","ror":"https://ror.org/00afp2z80"},{"id":"https://openalex.org/F4320328144","display_name":"Fondation contre le Cancer","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7221574479.pdf","grobid_xml":"https://content.openalex.org/works/W7221574479.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W1910012553","https://openalex.org/W1997183854","https://openalex.org/W2002490399","https://openalex.org/W2039123767","https://openalex.org/W2048727571","https://openalex.org/W2059099021","https://openalex.org/W2096435906","https://openalex.org/W2100413206","https://openalex.org/W2110567472","https://openalex.org/W2112280924","https://openalex.org/W2134539328","https://openalex.org/W2727828415","https://openalex.org/W2762087180","https://openalex.org/W2913095286","https://openalex.org/W2913137771","https://openalex.org/W2913973491","https://openalex.org/W2943793201","https://openalex.org/W2980472864","https://openalex.org/W3033869790","https://openalex.org/W3093085805","https://openalex.org/W3106235644","https://openalex.org/W3108493784","https://openalex.org/W3127468120","https://openalex.org/W3160339144","https://openalex.org/W4309003743","https://openalex.org/W4315796974","https://openalex.org/W4362641156","https://openalex.org/W4391878282","https://openalex.org/W4400568513","https://openalex.org/W4404070167","https://openalex.org/W4406336154","https://openalex.org/W7131793615","https://openalex.org/W7162815041","https://openalex.org/W7164519131","https://openalex.org/W7171985434","https://openalex.org/W7202215087"],"related_works":["https://openalex.org/W7129212321","https://openalex.org/W4409160401","https://openalex.org/W7155132334","https://openalex.org/W4399346451","https://openalex.org/W4390347742","https://openalex.org/W3181488342","https://openalex.org/W4382241966","https://openalex.org/W3159111758","https://openalex.org/W2592596865","https://openalex.org/W4388636575"],"abstract_inverted_index":{"Background":[0],"Triple-negative":[1],"breast":[2],"cancer":[3],"(TNBC)":[4],"is":[5],"a":[6,12,242],"heterogeneous":[7],"disease":[8],"that":[9,228],"often":[10],"exhibits":[11],"relatively":[13],"immunologically":[14],"\u201ccold\u201d":[15],"tumor":[16,183,209],"microenvironment,":[17],"which":[18],"can":[19],"limit":[20],"the":[21,118,129,182,239],"efficacy":[22,107,248],"of":[23,43,75,108,131,167,225],"immune":[24,46,100,149,168,230],"checkpoint":[25,47,169,236],"inhibitors":[26],"(ICIs).":[27],"Alterations":[28],"in":[29,151,191,207,249],"lipid":[30,33,221],"metabolism":[31],"and":[32,39,64,68,78,83,85,112,125,136,159,164,185,188,194,203,223,232],"peroxidation":[34,222],"may":[35],"influence":[36],"tumor\u2013immune":[37],"interactions":[38],"represent":[40],"potential":[41],"determinants":[42],"response":[44],"to":[45,98,235,245],"blockade.":[48,237],"Methods":[49],"Human":[50],"TNBC":[51,121,146,234],"cell":[52,69,76,179],"lines":[53],"(MDA-MB-231,":[54],"BT-549)":[55],"were":[56,93],"treated":[57,145],"with":[58,95,213],"ferroptosis":[59],"inducers":[60],"(FINs),":[61],"including":[62,134],"RSL3":[63,126],"SCD1":[65,174,201,218,240],"inhibitor":[66],"(SCD1i),":[67],"death":[70],"was":[71,81,88,115],"assessed.":[72],"Proteomic":[73],"profiling":[74],"lysates":[77],"conditioned":[79,96],"media":[80,97,143],"performed,":[82],"IL-8":[84,135],"MIF":[86],"secretion":[87],"quantified":[89],"by":[90,140,154],"ELISA.":[91,141],"Splenocytes":[92],"incubated":[94],"assess":[99],"activation":[101,150,231],"via":[102],"flow":[103],"cytometry.":[104],"In":[105,171],"vivo":[106,172],"SCD1i,":[109],"PD-1":[110,187],"blockade,":[111],"their":[113],"combination":[114],"evaluated":[116],"using":[117],"E0771":[119],"murine":[120],"model.":[122],"Results":[123],"SCD1i":[124],"treatment":[127,215],"induced":[128],"release":[130,224],"inflammatory":[132,226],"mediators,":[133],"MIF,":[137],"as":[138],"confirmed":[139],"Conditioned":[142],"from":[144],"cells":[147],"enhanced":[148],"splenocytes,":[152],"characterized":[153],"increased":[155,176,186],"effector":[156],"CD4":[157],"+":[158,161,196],"CD8":[160,195],"T-cell":[162],"populations":[163],"altered":[165],"expression":[166,190],"receptors.":[170],",":[173],"inhibition":[175,202,211,219],"CD8+":[177],"T":[178,197],"infiltration":[180],"into":[181],"microenvironment":[184],"LAG-3":[189],"both":[192],"CD4+":[193],"cells.":[198],"Notably,":[199],"combined":[200],"anti-PD-1":[204],"therapy":[205],"resulted":[206],"greater":[208],"growth":[210],"compared":[212],"either":[214],"alone.":[216],"Conclusion":[217],"promotes":[220],"factors":[227],"enhance":[229],"sensitize":[233],"Targeting":[238],"represents":[241],"promising":[243],"strategy":[244],"improve":[246],"ICI":[247],"TNBC.":[250]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-13T00:00:00"}